SGHT Strangle Strategy
SGHT (Sight Sciences, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
SGHT (Sight Sciences, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $266.6M, a beta of 2.38 versus the broader market, a 52-week range of 3.11-9.236, average daily share volume of 346K, a public-listing history dating back to 2021, approximately 216 full-time employees. These structural characteristics shape how SGHT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.38 indicates SGHT has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on SGHT?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current SGHT snapshot
As of May 15, 2026, spot at $4.97, ATM IV 206.40%, IV rank 43.69%, expected move 59.17%. The strangle on SGHT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on SGHT specifically: SGHT IV at 206.40% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 59.17% (roughly $2.94 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SGHT expiries trade a higher absolute premium for lower per-day decay. Position sizing on SGHT should anchor to the underlying notional of $4.97 per share and to the trader's directional view on SGHT stock.
SGHT strangle setup
The SGHT strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SGHT near $4.97, the first option leg uses a $5.22 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SGHT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SGHT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $5.22 | N/A |
| Buy 1 | Put | $4.72 | N/A |
SGHT strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
SGHT strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on SGHT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on SGHT
Strangles on SGHT are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SGHT chain.
SGHT thesis for this strangle
The market-implied 1-standard-deviation range for SGHT extends from approximately $2.03 on the downside to $7.91 on the upside. A SGHT long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current SGHT IV rank near 43.69% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on SGHT should anchor more to the directional view and the expected-move geometry. As a Healthcare name, SGHT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SGHT-specific events.
SGHT strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SGHT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SGHT alongside the broader basket even when SGHT-specific fundamentals are unchanged. Always rebuild the position from current SGHT chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on SGHT?
- A strangle on SGHT is the strangle strategy applied to SGHT (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With SGHT stock trading near $4.97, the strikes shown on this page are snapped to the nearest listed SGHT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SGHT strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the SGHT strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 206.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SGHT strangle?
- The breakeven for the SGHT strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SGHT market-implied 1-standard-deviation expected move is approximately 59.17%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on SGHT?
- Strangles on SGHT are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SGHT chain.
- How does current SGHT implied volatility affect this strangle?
- SGHT ATM IV is at 206.40% with IV rank near 43.69%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.